Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 19, 2025 • 11:01 AM ET

Date/Time Source News Release
06/11/2025 09:30 AM EDT ACCESS Newswire SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations
06/04/2025 09:30 AM EDT ACCESS Newswire SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development
05/06/2025 10:15 AM EDT ACCESS Newswire SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery
05/02/2025 10:30 AM EDT ACCESS Newswire Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization
05/01/2025 09:30 AM EDT ACCESS Newswire SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology
04/28/2025 09:30 AM EDT ACCESS Newswire SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies
04/16/2025 09:30 AM EDT ACCESS Newswire SOHM, Inc. Announces Patent Allowance/Approval in South Korea
04/10/2025 09:30 AM EDT ACCESS Newswire SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE
04/07/2025 09:30 AM EDT ACCESS Newswire SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations
03/10/2025 10:30 AM EDT ACCESS Newswire SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology
Page

Additional News

As of June 19, 2025 • 11:01 AM ET

Date/Time Source News Release
06/10/2024 01:45 PM EDT y%wire Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor
05/22/2024 01:30 PM EDT InvestorBrandNetwork InvestorNewsBreaks - SOHM, Inc. (SHMN) Continues to Advance Groundbreaking Technology
04/01/2024 10:00 AM EDT InvestorBrandNetwork InvestorNewsBreaks - SOHM, Inc. (SHMN), Coastar Therapeutics Collaborate to Advance Field of Genome Editing
03/11/2024 10:45 AM EDT InvestorBrandNetwork Rheumatoid Arthritis Patients Face Heightened Risk of Depression, Study Finds
02/21/2024 10:00 AM EST InvestorBrandNetwork FDA Grants Florida Permission to Import More Affordable Medicines from Canada
02/01/2024 02:15 PM EST InvestorBrandNetwork Why Prescription Drugs Can Be Costly
01/22/2024 11:00 AM EST InvestorBrandNetwork Small Study Shows Existing Drug Could Reduce Opioid Administration After Surgery
01/09/2024 10:00 AM EST InvestorBrandNetwork InvestorNewsBreaks - SOHM Inc. (SHMN) Announces Filing of Provisional Patent for ABBIE Smart Gene Editing Technology
01/09/2024 09:56 AM EST SeekingAlpha SOHM files provisional patent on its ABBIE 'smart gene-editing' platform
12/27/2023 03:15 PM EST InvestorBrandNetwork FDA Announces Changes to Safety Labeling Requirements for Opioid Medications
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.